Fundraising Fox
Metalead
1 known investors
Find your way into Metalead
Each arrow is one introduction. Sign up to fill in the first one.
417 people can intro you to Michal
Ask Christian Jaag to introduce you to Michal Shoshan
You →Christian · together at University of Zurich →Michal
Sign up to find every way you can get introduced to Metalead
- Your email: who you already know at Metalead, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Metalead team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.
Founders & leadership
MS
Michal ShoshanFounder and CEOMichal Shoshan is founder and CEO of metaLead Therapeutics AG, a University of Zurich spin-off focused on metal-centered medicine. He holds background in medicinal inorganic chemistry and chemical biology.
Investors · 1
Frequently asked questions
- What does Metalead do?
- metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.
- Who founded Metalead?
- Metalead was founded by Michal Shoshan.
- Who are Metalead's investors?
- Metalead's investors include Kickfund.